Researcher
Guido Vanham
Affiliations
- Virology (Research unit)
Member
From1 Jan 1989 → 30 Jul 2019
Projects
1 - 10 of 19
- Machine learning framework for T-cell receptor repertoire-based viral diagnosticsFrom3 Nov 2020 → Today
- Evaluation of the role of immune checkpoint molecules in the natural killer cell-mediated anti-HIV responseFrom11 Apr 2019 → Today
- Development of a novel nanoparticle formulation for mRNA based therapeutic vaccination against HIVFrom11 Apr 2019 → Today
- Immuno Cytometry: Phenotyping immune cellular components, in the context of HBV, HIV and AD, by new, advanced technologiesFrom18 Jan 2018 → 17 Aug 2020
- Interventions towards a functional cure: detailed phenotyping of the HIV-specific polyfunctional CD8+ T cell responses of controllersFrom24 Jun 2016 → 12 Feb 2020
- Search for host genetic factors associated with neurological complications (HAM/TSP) in Peruvian HTLV-1 infected individualsFrom18 May 2016 → 27 Sep 2016
- Rationeel ontwerp van een therapeutisch vaccin tegen HIV-1 gebaseerd op een nieuwe formulering van nanopartikelFrom1 Jan 2016 → 31 Dec 2020
- Cell-associated HIV-RNA as a superior marker of treatment success or failureFrom29 Apr 2015 → 19 Sep 2019
- Therapeutic TriMix/Mrna BASED Vaccine in Chronic HIV-1 Infected Patients Receiving Antiretroviral TherapyFrom1 Dec 2013 → 31 Dec 2017
- Inductie van breed-potente Hiv-1 suppressieve immuun responsen door dendritische cellen opgeladen met gag mRNA.From1 Jan 2011 → 21 Mar 2019
Publications
41 - 50 of 206
- Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate(2013)
Authors: M.L. Visciano, M. Tagliamonte, G. Stewart-Jones, L Heyndrickx, G Vanham, M. Jansson, A. Fomsgaard, B. Grevstad, M. Ramaswamy, F.M. Buonaguro, et al.
Pages: 1-11 - Type I IFN counteracts the induction of antigen-specific immune responses by lipid-based delivery of mRNA vaccines(2013)
Authors: C Pollard, J Rejman, W De Haes, B. Verrier, E. Van Gulck, T. Naessens, S. De Smedt, P. Bogaert, J. Grooten, G Vanham, et al.
Pages: 251-259 - The N276 glycosylation site is required for HIV-1 neutralization by the CD4 binding site specific HJ16 monoclonal antibody(2013)
Authors: SS Balla-Jhagjhoorsingh, D. Corti, L Heyndrickx, B Willems, K Vereecken, D. Davis, G Vanham
Pages: e68863 - In vitro and ex vivo evaluation of polymeric nanoparticles for vaginal and rectal delivery of the anti-HIV drug dapivirine(2013)
Authors: J. das Neves, F. Araujo, F. Andrade, J Michiels, Kevin Ariën, G Vanham, M. Amiji, M.F. Bahia, B. Sarmento
Pages: 2793-2807 - Interfacial cavity filling to optimize CD4-mimetic miniprotein interactions with the HIV-1 surface protein(2013)
Authors: L. Morellato-Castillo, P. Acharya, O. Combes, J Michiels, A Descours, O.H. Ramos, Y. Yang, G Vanham, Kevin Ariën, P.D. Kwong, et al.
Pages: 5033-5047 - Targeting of human antigen-presenting cell subsets(2013)
Authors: C. Goyvaerts, J. Dingemans, K. De Groeve, C. Heirman, E. Van Gulck, G Vanham, P. De Baetselier, K. Thielemans, G. Raes, K. Breckpot
Pages: 11304-11308 - M48U1 CD4 mimetic has a sustained inhibitory effect on cell-associated HIV-1 by attenuating virion infectivity through gp120 shedding(2013)
Authors: P Selhorst, K. Grupping, T. Tong, E.T. Crooks, L. Martin, G Vanham, J.M. Binley, Kevin Ariën
Pages: 1-9 - Selected HIV-1 env trimeric formulations act as potent immunogens in a rabbit vaccination model(2013)
Authors: L Heyndrickx, G. Stewart-Jones, M. Jansson, H. Schuitemaker, E. Bowles, L. Buonaguro, B. Grevstad, L. Vinner, K Vereecken, J. Parker, et al.
Pages: e74552 - Diaryltriazine non-nucleoside reverse transcriptase inhibitors are potent candidates for pre-exposure prophylaxis in the prevention of sexual HIV transmission(2013)
Authors: Kevin Ariën, M. Venkatraj, J Michiels, J. Joossens, K Vereecken, P. Van der Veken, Said Abdellati, Vicky Cuylaerts, Tania Crucitti, L Heyndrickx, et al.
Pages: 2038-2047 - Searching for lower female genital tract soluble and cellular biomarkers(2012)
Authors: J.K. Kyongo, Vicky Jespers, Odin Goovaerts, J Michiels, Joris Menten, R.N. Fichorova, Tania Crucitti, G Vanham, Kevin Ariën
Pages: e43951